During testosterone therapy, three groups of tests anchor safe monitoring: early-morning total testosterone to confirm the dose is in range; haematocrit / haemoglobin to detect blood thickening; and cardiovascular risk markers including lipid profile and blood pressure.
Guidelines (Endocrine Society, AUA) call for an initial review within months of starting and then periodic reassessment. A haematocrit rising above threshold typically means a pause or dose adjustment. These intervals are not bureaucratic — they are the guardrails for safely continuing therapy.
At BioBlend, every dispensed TRT cycle comes with a written monitoring schedule. If your latest results are overdue, your pharmacist will help you arrange them before the next refill.
References
1.Endocrine Society Clinical Practice Guideline — testosterone therapy (monitoring section).
2.American Urological Association Guideline — monitoring and discontinuation.
3.FDA Drug Safety Communications on testosterone therapy.
Book your appointment
Consultation
Sign in to book
You need an account to book and track your appointment in your dashboard.
